KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Other Accumulated Expenses (2016 - 2021)

Historic Other Accumulated Expenses for Resmed (RMD) over the last 12 years, with Q2 2021 value amounting to $12.3 million.

  • Resmed's Other Accumulated Expenses fell 177.05% to $12.3 million in Q2 2021 from the same period last year, while for Jun 2021 it was $12.3 million, marking a year-over-year decrease of 177.05%. This contributed to the annual value of $12.3 million for FY2021, which is 177.05% down from last year.
  • Latest data reveals that Resmed reported Other Accumulated Expenses of $12.3 million as of Q2 2021, which was down 177.05% from $12.5 million recorded in Q2 2020.
  • Over the past 5 years, Resmed's Other Accumulated Expenses peaked at $41.2 million during Q2 2019, and registered a low of $10.9 million during Q2 2017.
  • Moreover, its 5-year median value for Other Accumulated Expenses was $12.3 million (2021), whereas its average is $17.6 million.
  • As far as peak fluctuations go, Resmed's Other Accumulated Expenses soared by 27491.13% in 2019, and later tumbled by 6970.31% in 2020.
  • Quarter analysis of 5 years shows Resmed's Other Accumulated Expenses stood at $10.9 million in 2017, then increased by 0.93% to $11.0 million in 2018, then surged by 274.91% to $41.2 million in 2019, then tumbled by 69.7% to $12.5 million in 2020, then dropped by 1.77% to $12.3 million in 2021.
  • Its Other Accumulated Expenses stands at $12.3 million for Q2 2021, versus $12.5 million for Q2 2020 and $41.2 million for Q2 2019.